众生药业
(002317)
| 流通市值：198.38亿 | | | 总市值：219.54亿 |
| 流通股本：7.68亿 | | | 总股本：8.50亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,000,420,115.22 | 624,239,320.67 | 2,522,737,619.7 | 1,888,753,875.6 |
| 营业总成本 | 888,603,999.58 | 514,225,795.98 | 2,225,746,035.9 | 1,625,683,280.09 |
| 其他经营收益 | | | | |
| 营业利润 | 119,313,529.36 | 112,190,162.14 | 298,299,493.92 | 288,738,830.68 |
| 利润总额 | 123,598,450.96 | 117,692,336.37 | 296,585,833.52 | 287,336,316.04 |
| 净利润 | 106,746,970.3 | 98,025,231.34 | 266,704,568.89 | 245,497,657.34 |
| 每股收益 | | | | |
| 其他综合收益 | -810,552.41 | -465,901.91 | -5,349,740.05 | -6,583,447.99 |
| 综合收益总额 | 105,936,417.89 | 97,559,329.43 | 261,354,828.84 | 238,914,209.35 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,021,095,580.31 | 3,430,641,844.35 | 3,043,657,559.41 | 3,098,722,883.07 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,946,316,184.16 | 1,911,178,346.69 | 2,085,889,813.67 | 2,068,632,419.32 |
| 资产总计 | 4,967,411,764.47 | 5,341,820,191.04 | 5,129,547,373.08 | 5,167,355,302.39 |
| 流动负债: | | | | |
| 流动负债合计 | 621,645,697.49 | 829,584,469.9 | 718,319,427.71 | 830,222,745.35 |
| 非流动负债: | | | | |
| 非流动负债合计 | 254,671,277.42 | 262,239,384.39 | 261,386,177.8 | 211,294,005.01 |
| 负债合计 | 876,316,974.91 | 1,091,823,854.29 | 979,705,605.51 | 1,041,516,750.36 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,004,184,524.29 | 4,160,206,822.87 | 4,058,166,288.88 | 4,029,980,658.02 |
| 股东权益合计 | 4,091,094,789.56 | 4,249,996,336.75 | 4,149,841,767.57 | 4,125,838,552.03 |
| 负债和股东权益合计 | 4,967,411,764.47 | 5,341,820,191.04 | 5,129,547,373.08 | 5,167,355,302.39 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,494,245,241.64 | 672,674,121.41 | 2,362,757,029.65 | 1,679,559,979.54 |
| 经营活动现金流出小计 | 952,491,909.37 | 531,139,427.04 | 2,057,552,446.97 | 1,524,574,853.8 |
| 经营活动产生的现金流量净额 | 541,753,332.27 | 141,534,694.37 | 305,204,582.68 | 154,985,125.74 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 502,623,282.47 | 133,042,420.55 | 1,307,334,963.47 | 786,528,997.83 |
| 投资活动现金流出小计 | 920,100,144.38 | 488,410,357.59 | 1,261,170,977.1 | 849,678,273.01 |
| 投资活动产生的现金流量净额 | -417,476,861.91 | -355,367,937.04 | 46,163,986.37 | -63,149,275.18 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 21,887,979.43 | 18,791,591 | 398,206,741.24 | 277,734,247.37 |
| 筹资活动现金流出小计 | 383,909,356.43 | 50,619,886.95 | 1,133,736,011.74 | 801,887,356.93 |
| 筹资活动产生的现金流量净额 | -362,021,377 | -31,828,295.95 | -735,529,270.5 | -524,153,109.56 |
| 汇率变动对现金及现金等价物的影响 | -41,578.85 | -20,914.64 | -30,491.28 | -15,840.3 |
| 现金及现金等价物净增加额 | -237,786,485.49 | -245,682,453.26 | -384,191,192.73 | -432,333,099.3 |
| 期末现金及现金等价物余额 | 740,106,883.78 | 732,210,916.01 | 977,893,369.27 | 929,751,462.7 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -237,786,485.49 | - | -384,191,192.73 | - |
最新报告期：2026-09-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东海证券 | 杜永宏 | 0.41 | 0.47 | 0.56 | 2026-09-08 |
| 国投证券 | 冯俊曦,连国强 | 0.27 | 0.38 | 0.50 | 2026-09-02 |
| 开源证券 | 余汝意,巢舒然 | 0.25 | 0.35 | 0.40 | 2026-08-27 |